BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $211,000 | -44.3% | 105,362 | -0.7% | 0.84% | -65.7% |
| Q4 2018 | $379,000 | +15.2% | 106,100 | 0.0% | 2.45% | +44.2% |
| Q3 2018 | $329,000 | -2.1% | 106,100 | -7.4% | 1.70% | +13.6% |
| Q2 2018 | $336,000 | +48.0% | 114,541 | +24.3% | 1.49% | +56.2% |
| Q1 2018 | $227,000 | -14.7% | 92,159 | +1.0% | 0.96% | -20.7% |
| Q4 2017 | $266,000 | -18.9% | 91,279 | -23.4% | 1.21% | -21.9% |
| Q3 2017 | $328,000 | +4.1% | 119,169 | +2.6% | 1.54% | +3.8% |
| Q2 2017 | $315,000 | – | 116,153 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |